This symposium is intended to provide a new paradigm in the treatment options for lung cancer and head & neck cancer. In addition to chemotherapy and targeted therapy, this symposium will focus on individualized therapy based on emerging agents currently in development and symptom control and management of toxicity issues. The format will include didactic lectures from known opinion leaders, question and answer sessions, case report presentation and ample opportunity for participant interaction with faculty. In-depth discussion of novel agents at various stages of clinical development for lung cancer and head & neck cancer will be given significant focus.